ES2138950T1 - Nuevo procedimiento. - Google Patents

Nuevo procedimiento.

Info

Publication number
ES2138950T1
ES2138950T1 ES98953132T ES98953132T ES2138950T1 ES 2138950 T1 ES2138950 T1 ES 2138950T1 ES 98953132 T ES98953132 T ES 98953132T ES 98953132 T ES98953132 T ES 98953132T ES 2138950 T1 ES2138950 T1 ES 2138950T1
Authority
ES
Spain
Prior art keywords
metoxi
new procedure
piridinil
dimetil
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES98953132T
Other languages
English (en)
Spanish (es)
Inventor
Hanna Cotton
Magnus Larsson
Anders Mattson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of ES2138950T1 publication Critical patent/ES2138950T1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
ES98953132T 1997-11-14 1998-11-03 Nuevo procedimiento. Pending ES2138950T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704183A SE9704183D0 (sv) 1997-11-14 1997-11-14 New process

Publications (1)

Publication Number Publication Date
ES2138950T1 true ES2138950T1 (es) 2000-02-01

Family

ID=20408989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98953132T Pending ES2138950T1 (es) 1997-11-14 1998-11-03 Nuevo procedimiento.

Country Status (35)

Country Link
US (1) US6303788B1 (en, 2012)
EP (1) EP0964859A1 (en, 2012)
JP (1) JP2001508466A (en, 2012)
KR (1) KR20000070069A (en, 2012)
CN (1) CN1145624C (en, 2012)
AR (1) AR013740A1 (en, 2012)
AU (1) AU750743B2 (en, 2012)
BR (1) BR9806871A (en, 2012)
CA (1) CA2276753A1 (en, 2012)
DE (1) DE964859T1 (en, 2012)
DZ (1) DZ2641A1 (en, 2012)
EE (1) EE04154B1 (en, 2012)
ES (1) ES2138950T1 (en, 2012)
GR (1) GR990300046T1 (en, 2012)
HR (1) HRP990218A2 (en, 2012)
HU (1) HUP0003737A3 (en, 2012)
ID (1) ID21999A (en, 2012)
IL (1) IL130647A0 (en, 2012)
IN (1) IN190801B (en, 2012)
IS (1) IS5106A (en, 2012)
MA (1) MA26564A1 (en, 2012)
MY (1) MY118199A (en, 2012)
NO (1) NO318197B1 (en, 2012)
NZ (1) NZ336447A (en, 2012)
PL (1) PL334701A1 (en, 2012)
RU (1) RU2211218C2 (en, 2012)
SE (1) SE9704183D0 (en, 2012)
SK (1) SK87299A3 (en, 2012)
TN (1) TNSN98202A1 (en, 2012)
TR (1) TR199901643T1 (en, 2012)
TW (1) TW588046B (en, 2012)
UA (1) UA68342C2 (en, 2012)
WO (1) WO1999025711A1 (en, 2012)
YU (1) YU31199A (en, 2012)
ZA (1) ZA989999B (en, 2012)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
CZ20032351A3 (cs) 2001-02-02 2004-08-18 Tevaápharmaceuticaláindustriesáltd Způsob výroby substituovaných @@}@@pyridylmethylB sulfinyl @�H@benzimidazolů
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005016705D1 (de) 2004-10-11 2009-10-29 Ranbaxy Lab Ltd Verfahren zur herstellung substituierter sulfoxide
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
CN102603621B (zh) * 2012-02-07 2013-09-04 成都苑东药业有限公司 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法
CN106083819A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种奥美拉唑的制备方法
ES2948511A1 (es) * 2021-09-08 2023-09-13 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Derivados de n-sulfonilureas y su uso terapeutico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
WO1993006097A1 (en) 1991-09-20 1993-04-01 Merck & Co., Inc. Novel process for the preparation of anti-ulcer agents
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider

Also Published As

Publication number Publication date
AU750743B2 (en) 2002-07-25
MY118199A (en) 2004-09-30
PL334701A1 (en) 2000-03-13
TR199901643T1 (xx) 2000-01-21
UA68342C2 (en) 2004-08-16
HRP990218A2 (en) 2000-08-31
IS5106A (is) 1999-07-02
IL130647A0 (en) 2000-06-01
GR990300046T1 (en) 2000-07-31
TNSN98202A1 (fr) 2005-03-15
EP0964859A1 (en) 1999-12-22
RU2211218C2 (ru) 2003-08-27
AR013740A1 (es) 2001-01-10
YU31199A (sh) 2002-06-19
IN190801B (en, 2012) 2003-08-23
EE04154B1 (et) 2003-10-15
WO1999025711A1 (en) 1999-05-27
BR9806871A (pt) 2000-04-18
NZ336447A (en) 2001-02-23
DE964859T1 (de) 2000-05-04
CN1243512A (zh) 2000-02-02
SK87299A3 (en) 2000-02-14
HUP0003737A2 (hu) 2001-10-28
EE9900391A (et) 2000-04-17
CN1145624C (zh) 2004-04-14
JP2001508466A (ja) 2001-06-26
ID21999A (id) 1999-08-19
ZA989999B (en) 1999-06-17
SE9704183D0 (sv) 1997-11-14
TW588046B (en) 2004-05-21
NO318197B1 (no) 2005-02-14
US6303788B1 (en) 2001-10-16
DZ2641A1 (fr) 2003-03-15
NO993298L (no) 1999-07-02
CA2276753A1 (en) 1999-05-27
MA26564A1 (fr) 2004-12-20
KR20000070069A (ko) 2000-11-25
HUP0003737A3 (en) 2002-01-28
NO993298D0 (no) 1999-07-02
AU1058299A (en) 1999-06-07

Similar Documents

Publication Publication Date Title
ES2138950T1 (es) Nuevo procedimiento.
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
GEP20063996B (en) Aripiprazole complex formulation and use thereof
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
NO20013469L (no) Fremgangsmåter for glukagonsuppresjon
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ATE292453T1 (de) Antivirale arznei
ATE324886T1 (de) Feste arzneizusammensetzung enthaltend 4'-cyano- trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy- 2-methylpropiono- m toluidide und pvp
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
AU2003293593A8 (en) Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
BR0209103A (pt) Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
CO5261595A1 (es) Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium
IT1292092B1 (it) Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
DK1152763T3 (da) Anvendelse af desozypeganin til behandling af stofafhængighed
ATE295169T1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
Murphy New antiretroviral drugs part I: PIs
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
ECSP982679A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa
NO20033118L (no) Mikanolide-derivater, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdom
ATE334675T1 (de) Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole